Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

As Some Pharma Companies Exit Facebook, Device Firms Stay Connected

This article was originally published in The Pink Sheet Daily

Executive Summary

Although the new Facebook policy wasn't directed at medical device firms, some device companies have taken initiatives on their own to either closely monitor or, in some cases, delete all of the public comments on their Facebook walls

You may also be interested in...



User Fee Package Offers FDA Reforms From A House Wary Of FDA Power

House drafters’ dissatisfaction with FDA’s performance is evident in several provisions of draft user fee legislation. The agency would be required to finalize some guidances within a year of issuing a draft, which likely would provide more predictability for industry.

DTC Pre-Review Guidance In The Works For Rx TV Ads, FDA’s Abrams Says

Certain drug classes will be required to submit certain types of ads, according to Tom Abrams, director of CDER’s recently elevated Office of Prescription Drug Promotion, but specifics will await the guidance itself.

To Tweet Or Not To Tweet? Social Media Marketing Guidance Is There If You Look For It, Experts Say

Device and drug firms waiting for FDA to issue guidance on how best to use social media for marketing and promotion can look instead at existing regulations both in and outside the agency, experts said recently.

Topics

UsernamePublicRestriction

Register

PS072671

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel